A rare genetic condition that affects only a tiny fraction of the global population is finally gaining traction in the medical world—and it’s opening new doors to hope innovation and targeted therapies. For years Schwartz Jampel syndrome has remained in the shadows but now a surge in research and drug development is turning the spotlight on this highly complex disorder...